|
Delayed
Sao Paulo
20:35:54 29/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 10.41 BRL | -8.67% |
|
-32.95% | -13.09% |
Company Valuation: Dimed S.A. Distribuidora de Medicamentos
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,980 | 1,507 | 1,989 | 1,314 | 1,790 | 1,583 | - | - |
| Change | - | -23.88% | 31.94% | -33.91% | 36.16% | -11.52% | - | - |
| Enterprise Value (EV) 1 | 1,904 | 1,585 | 2,126 | 1,656 | 2,071 | 1,920 | 1,923 | 1,960 |
| Change | - | -16.77% | 34.14% | -22.12% | 25.1% | -7.27% | 0.12% | 1.95% |
| P/E | 25.1x | 17.5x | 21.5x | 12.6x | 14.4x | 9.15x | 6.97x | 5.58x |
| PBR | 1.9x | 1.36x | 1.69x | 1.07x | 1.39x | 1.12x | 1.01x | 0.9x |
| PEG | - | 1.86x | 3.12x | 1x | 0.8x | 0.2x | 0.2x | 0.2x |
| Capitalization / Revenue | 0.61x | 0.38x | 0.45x | 0.27x | 0.32x | 0.25x | 0.22x | 0.19x |
| EV / Revenue | 0.59x | 0.4x | 0.48x | 0.33x | 0.38x | 0.3x | 0.26x | 0.24x |
| EV / EBITDA | 6.7x | 7.81x | 9.12x | 6.29x | 6.48x | 4.96x | 4.17x | 3.64x |
| EV / EBIT | 16.4x | 10.8x | 12.9x | 8.48x | 8.13x | 6.6x | 5.48x | 4.7x |
| EV / FCF | - | - | 11.7x | 16.3x | 5.9x | 21.1x | -137x | 392x |
| FCF Yield | - | - | 8.57% | 6.14% | 16.9% | 4.74% | -0.73% | 0.26% |
| Dividend per Share 2 | - | 0.1431 | 0.2516 | - | - | 0.4559 | 0.4454 | 0.5679 |
| Rate of return | - | 1.41% | 1.88% | - | - | 4.3% | 4.2% | 5.36% |
| EPS 2 | 0.53 | 0.58 | 0.62 | 0.7 | 0.83 | 1.159 | 1.521 | 1.9 |
| Distribution rate | - | 24.7% | 40.6% | - | - | 39.3% | 29.3% | 29.9% |
| Net sales 1 | 3,225 | 3,990 | 4,461 | 4,942 | 5,512 | 6,412 | 7,308 | 8,266 |
| EBITDA 1 | 284.3 | 202.8 | 233 | 263.1 | 319.4 | 387.5 | 461.6 | 538.6 |
| EBIT 1 | 116.1 | 147.1 | 165.1 | 195.3 | 254.7 | 290.9 | 351.1 | 417.4 |
| Net income 1 | 121.6 | 97.7 | 92.9 | 105.5 | 124.6 | 171.8 | 221.2 | 271.9 |
| Net Debt 1 | -75.83 | 77.5 | 137.1 | 341.2 | 281.5 | 337.1 | 339.4 | 376.8 |
| Reference price 2 | 13.32 | 10.14 | 13.36 | 8.80 | 11.99 | 10.60 | 10.60 | 10.60 |
| Nbr of stocks (in thousands) | 148,648 | 148,644 | 148,852 | 149,358 | 149,257 | 149,376 | - | - |
| Announcement Date | 24/03/22 | 23/03/23 | 14/03/24 | 28/03/25 | 20/03/26 | - | - | - |
1BRL in Million2BRL
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 9.15x | 0.3x | 4.96x | 4.3% | 295M | ||
| 16.5x | 0.66x | 9.82x | -.--% | 14.81B | ||
| 16.4x | 0.73x | 7.57x | 2.28% | 6.26B | ||
| 20.27x | 0.35x | 5.31x | 2.25% | 6.16B | ||
| 19.23x | 0.69x | 11.95x | 1.14% | 5.75B | ||
| 18.26x | 0.8x | 8.69x | 2.46% | 5.11B | ||
| 16.01x | 1x | 6.98x | 2.64% | 4.53B | ||
| 14.87x | 0.43x | 7.13x | 1.42% | 3.02B | ||
| 14.15x | 0.6x | 4.62x | 5.1% | 3.15B | ||
| 14.86x | 0.88x | 6.62x | 4.36% | 2.99B | ||
| Average | 15.97x | 0.64x | 7.36x | 2.59% | 5.21B | |
| Weighted average by Cap. | 16.99x | 0.67x | 8.21x | 1.8% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- PNVL3 Stock
- Valuation Dimed S.A. Distribuidora de Medicamentos
Select your edition
All financial news and data tailored to specific country editions
















